Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Advanced Biomed Inc. (ADVB) had Return on Tangible Equity of -33.68% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-1.38M |
|
-- |
|
-- |
|
$0.76M |
|
$-0.76M |
|
$-0.62M |
|
$-1.38M |
|
$-1.38M |
|
$-1.38M |
|
$-1.38M |
|
$-1.38M |
|
$-1.38M |
|
$-0.76M |
|
$-0.68M |
|
20.48M |
|
20.48M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$7.73M |
|
$0.36M |
|
$0.56M |
|
$8.29M |
|
$4.11M |
|
-- |
|
$0.04M |
|
$4.16M |
|
$4.13M |
|
$4.11M |
|
$4.13M |
|
21.64M |
|
| Cash Flow Statement Financials | |
$-4.28M |
|
$-0.01M |
|
$6.70M |
|
$2.61M |
|
$5.18M |
|
$2.58M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.88 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.29M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-33.51% |
|
|
Return on Tangible Equity |
-33.68% |
-16.70% |
|
-33.51% |
|
$0.19 |
|
$-0.21 |
|
$-0.21 |
|